UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 20, 2021

ADVANCED BIOENERGY, LLC
(Exact name of Registrant as Specified in Charter)
	Delaware
(State or Other Jurisdiction of Incorporation)
000-52421		20-2281511
(Commission File Number)		(I.R.S. Employer Identification No.)
Box 201759 Bloomington, Minnesota		55420
(Address of Principal Executive Offices)		(Zip Code)
Registrant’s Telephone Number, Including Area Code: None

Securities registered pursuant to Section 12(b) of the Act: None

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01.

Other Events.

Beginning on or about July 20, 2021, Advanced BioEnergy, LLC, (the “Company”) sent a letter to its Members updating them of the status of its Liquidation and Dissolution. Each Member was also sent a final distribution check for $0.332 per unit, or approximately $8.5 million in aggregate, for the 25,610,851 ABE units outstanding. A copy of the Member letter is attached as Exhibit 99.1.

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits

The Following is filed as an exhibit to this Report:

Exhibit No.	Description of Exhibit

99.1	Advanced BioEnergy, LLC July 2021 Letter to Members

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ADVANCED BIOENERGY, LLC

	By:	/s/ J.D. Schlieman
	J.D. Schlieman, Continuing Director

Date: July 26, 2021

Advanced BioEnergy, LLC 8-K